Background
N-terminal pro-brain natriuretic peptide (NT-proBNP) plasma levels may
predict a future cancer diagnosis (CD) in patients with coronary artery
disease (CAD). In this paper we test whether this could merely represent
the detection of increased NT-proBNP levels in subclinical tumors.